+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
From
Type 2 Diabetes Market Report and Forecast 2024-2032 - Product Thumbnail Image

Type 2 Diabetes Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
From
From
Coronary Artery Disease Global Market Report 2024 - Product Thumbnail Image

Coronary Artery Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Global Oncolytic Virus Therapy Market Outlook to 2035 - Product Thumbnail Image

Global Oncolytic Virus Therapy Market Outlook to 2035

  • Report
  • April 2023
  • 144 Pages
  • Global
From
From
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2024 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

  • Report
  • January 2020
  • 410 Pages
  • Global
From
From
Loading Indicator